Latest Insider Transactions at Ligand Pharmaceuticals Inc (LGND)
This section provides a real-time view of insider transactions for Ligand Pharmaceuticals Inc (LGND). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of LIGAND PHARMACEUTICALS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of LIGAND PHARMACEUTICALS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 15
2021
|
John L Higgins Director |
SELL
Payment of exercise price or tax liability
|
Direct |
5,212
-0.51%
|
$896,464
$172.46 P/Share
|
|
Feb 15
2021
|
Matthew W Foehr |
SELL
Payment of exercise price or tax liability
|
Direct |
3,098
-0.62%
|
$532,856
$172.46 P/Share
|
|
Feb 15
2021
|
Charles S Berkman |
SELL
Payment of exercise price or tax liability
|
Direct |
1,015
-1.18%
|
$174,580
$172.46 P/Share
|
|
Feb 11
2021
|
Todd C Davis Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,474
+4.7%
|
$482,430
$195.91 P/Share
|
|
Feb 10
2021
|
Todd C Davis Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,083
-9.63%
|
$1,082,679
$213.14 P/Share
|
|
Feb 09
2021
|
Stephen L Sabba Director |
SELL
Open market or private sale
|
Direct |
14,670
-19.02%
|
$3,051,360
$208.28 P/Share
|
|
Feb 09
2021
|
Stephen L Sabba Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,670
+17.28%
|
$161,370
$11.33 P/Share
|
|
Feb 05
2021
|
John L Higgins Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,970
-0.86%
|
$602,910
$203.03 P/Share
|
|
Feb 05
2021
|
John L Higgins Director |
BUY
Exercise of conversion of derivative security
|
Direct |
114,666
+14.3%
|
$1,375,992
$12.26 P/Share
|
|
Feb 05
2021
|
John L Higgins Director |
SELL
Open market or private sale
|
Direct |
54,666
-16.05%
|
$11,097,198
$203.4 P/Share
|
|
Feb 04
2021
|
Matthew W Foehr |
SELL
Open market or private sale
|
Direct |
44,547
-20.94%
|
$7,840,272
$176.86 P/Share
|
|
Feb 04
2021
|
Matthew W Foehr |
BUY
Exercise of conversion of derivative security
|
Direct |
45,547
+8.95%
|
$2,186,256
$48.17 P/Share
|
|
Feb 04
2021
|
Charles S Berkman |
SELL
Open market or private sale
|
Direct |
18,097
-38.5%
|
$3,221,266
$178.5 P/Share
|
|
Feb 03
2021
|
Matthew E Korenberg President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
10,819
+20.58%
|
-
|
|
Feb 03
2021
|
John L Higgins Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,608
+4.22%
|
-
|
|
Feb 03
2021
|
Matthew W Foehr |
BUY
Grant, award, or other acquisition
|
Direct |
6,595
+3.79%
|
-
|
|
Feb 03
2021
|
Charles S Berkman |
BUY
Grant, award, or other acquisition
|
Direct |
3,491
+6.91%
|
-
|
|
Jan 27
2021
|
Todd C Davis Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,456
+4.45%
|
$277,528
$113.5 P/Share
|
|
Jan 27
2021
|
John L Higgins Director |
BUY
Exercise of conversion of derivative security
|
Direct |
70,000
+11.13%
|
$1,260,000
$18.2 P/Share
|
|
Jan 27
2021
|
John L Higgins Director |
SELL
Open market or private sale
|
Direct |
40,000
-14.11%
|
$7,280,000
$182.0 P/Share
|
|
Jan 25
2021
|
Charles S Berkman |
SELL
Payment of exercise price or tax liability
|
Direct |
1,339
-1.54%
|
$208,884
$156.06 P/Share
|
|
Jan 25
2021
|
Charles S Berkman |
BUY
Grant, award, or other acquisition
|
Direct |
3,736
+4.09%
|
-
|
|
Jan 25
2021
|
Matthew E Korenberg President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,111
-3.41%
|
$329,316
$156.01 P/Share
|
|
Jan 25
2021
|
Matthew E Korenberg President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
7,108
+10.23%
|
-
|
|
Jan 25
2021
|
Matthew W Foehr |
SELL
Payment of exercise price or tax liability
|
Direct |
3,325
-1.03%
|
$518,700
$156.01 P/Share
|
|
Jan 25
2021
|
Matthew W Foehr |
BUY
Grant, award, or other acquisition
|
Direct |
8,515
+2.57%
|
-
|
|
Jan 25
2021
|
John L Higgins Director |
SELL
Payment of exercise price or tax liability
|
Direct |
7,441
-1.52%
|
$1,160,796
$156.01 P/Share
|
|
Jan 25
2021
|
John L Higgins Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,553
+3.07%
|
-
|
|
Jan 25
2021
|
John L Higgins Director |
SELL
Open market or private sale
|
Direct |
50,000
-17.52%
|
$7,950,000
$159.0 P/Share
|
|
Jan 25
2021
|
John L Higgins Director |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+14.91%
|
$700,000
$14.47 P/Share
|
|
Dec 31
2020
|
John L Higgins Director |
BUY
Other acquisition or disposition
|
Direct |
223
+0.09%
|
$18,732
$84.53 P/Share
|
|
Dec 08
2020
|
John L Higgins Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,683
-0.71%
|
$146,421
$87.52 P/Share
|
|
Dec 08
2020
|
John L Higgins Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,657
+5.83%
|
$146,570
$10.05 P/Share
|
|
Nov 09
2020
|
John L Higgins Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,458
-1.09%
|
$199,098
$81.77 P/Share
|
|
Nov 09
2020
|
John L Higgins Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+8.18%
|
$200,000
$10.05 P/Share
|
|
Nov 02
2020
|
Sunil Patel |
BUY
Open market or private purchase
|
Direct |
1,000
+3.43%
|
$82,000
$82.52 P/Share
|